#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Arrhythmogenic right ventricular dysplasia HER2 gene amplification Orthostatic hypotension Atypical haemolytic uraemic syndrome Adrenogenital syndrome Nodal marginal zone B-cell lymphoma Germ cell cancer Haemolytic uraemic syndrome Glomerulonephritis membranoproliferative Prolymphocytic leukaemia Marginal zone lymphoma Neuroendocrine cell hyperplasia of infancy Duchenne muscular dystrophy gene carrier Follicle centre lymphoma follicular grade I, II – III Small intestine adenocarcinoma More trials…

    Learn about Rare Diseases

    Angiosarcoma recurrent – Life with Disease Fabry’s disease Hereditary angioedema – Life with Disease Encephalitis autoimmune – Life with Disease Hereditary angioedema with C1 esterase inhibitor deficiency – Diagnostics Leukoencephalopathy – Trials in Disease Leiomyosarcoma metastatic – Basic Information Medulloblastoma – Treatment Osteosarcoma recurrent – Life with Disease Erdheim-Chester disease – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Oritavancin Specific Nucleic Acid Sna-Veru Exenatide GSKVX000000034792 Glucose Monohydrate SOFOSBUVIR Rusfertide Timolol Maleate Bi 764524 BI-1607 ATIGOTATUG Bay 3283142 Sodium Lactate Rbl007.2 Elotuzumab Vemurafenib Sapablursen Calcitriol Spesolimab IDROXIOLEIC ACID More therapies…

    Learn about Your Condition

    Colon cancer stage II Chondropathy Diarrhoea HER2 positive breast cancer Periarthritis Cataract Connective tissue disorder Testicular germ cell tumour Colon cancer stage IV Thrombocytopenia Vascular dementia Rasmussen encephalitis Supranuclear palsy Migraine Schizophrenia More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Pathological Conditions, Signs and Symptoms

  • Study on the Safety and Effectiveness of Apixaban, Edoxaban, and Phenprocoumon for Patients with Chronic Thromboembolic Pulmonary Hypertension Undergoing Balloon Pulmonary Angioplasty

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Embolism
    • Pulmonary hypertension
    Investigated Drugs:
    • Acenocoumarol
    • Dabigatran Etexilate
    • Phenprocoumon
    The Netherlands

  • Study of Monalizumab and Volrustomig for Patients with MSI and/or dMMR Metastatic Cancer

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Microsatellite instability cancer
    Investigated Drugs:
    • Monalizumab
    • Volrustomig
    France

  • Remote Study on Empagliflozin and Finerenone for Reducing Kidney Issues in Type 2 Diabetes Patients

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Albuminuria
    • Diabetic nephropathy
    • Type 2 diabetes mellitus
    Investigated Drugs:
    • Empagliflozin
    • Finerenone
    The Netherlands

  • Study Comparing Aliskiren and Enalapril for Patients with C3 Glomerulopathy

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • C3 glomerulopathy
    Investigated Drugs:
    • Aliskiren
    • Enalapril Maleate
    Sweden

  • Study on the Safety and Effectiveness of R2R01 and Terlipressin for Patients with Hepatorenal Syndrome and Acute Kidney Injury

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Hepatorenal syndrome
    • Acute kidney injury
    Investigated Drugs:
    • R2R01
    • Terlipressin Acetate
    Germany Italy

  • Study on the Effects of Tigulixostat and Allopurinol in Patients with Gout and High Uric Acid Levels

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Allopurinol
    • Autumn Crocus Fresh Flower Fluid Extract (1:15-25), Extraction Solvent Ethanol 96% (V/V)
    • Tigulixostat
    Belgium Bulgaria Czechia France Germany Italy +3
Previous Page
1 … 16 17 18 19 20 21
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!